Wedbush Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.88M | Sell |
202,441
-4,294
| -2% | -$112K | 0.13% | 123 |
|
|
2026
Q1 | $5.8M | Buy |
206,735
+13,967
| +7% | +$372K | 0.17% | 91 |
|
|
2025
Q4 | $4.8M | Buy |
192,768
+19,182
| +11% | +$484K | 0.14% | 109 |
|
|
2025
Q3 | $4.42M | Buy |
173,586
+4,316
| +3% | +$107K | 0.14% | 103 |
|
|
2025
Q2 | $4.1M | Sell |
169,270
-11,756
| -6% | -$274K | 0.14% | 109 |
|
|
2025
Q1 | $4.59M | Sell |
181,026
-21,212
| -10% | -$555K | 0.17% | 93 |
|
|
2024
Q4 | $5.37M | Buy |
202,238
+5,697
| +3% | +$155K | 0.19% | 77 |
|
|
2024
Q3 | $5.69M | Sell |
196,541
-54,221
| -22% | -$1.58M | 0.21% | 72 |
|
|
2024
Q2 | $7.02M | Buy |
250,762
+43,635
| +21% | +$1.2M | 0.25% | 62 |
|
|
2024
Q1 | $5.75M | Sell |
207,127
-117
| -0.1% | -$3.25K | 0.21% | 75 |
|
|
2023
Q4 | $5.97M | Sell |
207,244
-8,236
| -4% | -$249K | 0.26% | 62 |
|
|
2023
Q3 | $7.15M | Buy |
215,480
+43
| +0% | +$1.52K | 0.36% | 49 |
|
|
2023
Q2 | $7.9M | Sell |
215,437
-9,135
| -4% | -$356K | 0.38% | 38 |
|
|
2023
Q1 | $9.16M | Buy |
224,572
+10,362
| +5% | +$448K | 0.46% | 28 |
|
|
2022
Q4 | $11M | Sell |
214,210
-7,126
| -3% | -$342K | 0.6% | 22 |
|
|
2022
Q3 | $9.69M | Buy |
221,336
+3,024
| +1% | +$147K | 0.54% | 25 |
|
|
2022
Q2 | $11.4M | Buy |
218,312
+3,111
| +1% | +$159K | 0.62% | 22 |
|
|
2022
Q1 | $11.1M | Buy |
215,201
+9,420
| +5% | +$489K | 0.51% | 26 |
|
|
2021
Q4 | $12.2M | Buy |
205,781
+5,459
| +3% | +$270K | 0.52% | 25 |
|
|
2021
Q3 | $8.62M | Buy |
200,322
+7,854
| +4% | +$348K | 0.41% | 37 |
|
|
2021
Q2 | $7.54M | Buy |
192,468
+17,585
| +10% | +$684K | 0.36% | 43 |
|
|
2021
Q1 | $6.34M | Buy |
174,883
+9,593
| +6% | +$341K | 0.35% | 43 |
|
|
2020
Q4 | $6.08M | Sell |
165,290
-10,770
| -6% | -$395K | 0.53% | 34 |
|
|
2020
Q3 | $6.13M | Buy |
176,060
+8,332
| +5% | +$292K | 0.59% | 25 |
|
|
2020
Q2 | $5.2M | Buy |
167,728
+4,886
| +3% | +$166K | 0.49% | 40 |
|
|
2020
Q1 | $5.04M | Buy |
162,842
+11,028
| +7% | +$376K | 0.6% | 29 |
|
|
2019
Q4 | $5.64M | Buy |
151,814
+6,514
| +4% | +$232K | 0.5% | 32 |
|
|
2019
Q3 | $4.95M | Buy |
145,300
+8,062
| +6% | +$293K | 0.48% | 37 |
|
|
2019
Q2 | $5.64M | Buy |
137,238
+6,535
| +5% | +$259K | 0.57% | 25 |
|
|
2019
Q1 | $5.27M | Buy |
130,703
+10,045
| +8% | +$402K | 0.57% | 26 |
|
|
2018
Q4 | $5M | Buy |
120,658
+12,302
| +11% | +$511K | 0.64% | 25 |
|
|
2018
Q3 | $4.53M | Sell |
108,356
-11,103
| -9% | -$427K | 0.51% | 29 |
|
|
2018
Q2 | $4.11M | Sell |
119,459
-8,890
| -7% | -$304K | 0.51% | 30 |
|
|
2018
Q1 | $4.32M | Sell |
128,349
-9,346
| -7% | -$321K | 0.56% | 26 |
|
|
2017
Q4 | $4.73M | Sell |
137,695
-9,862
| -7% | -$336K | 0.58% | 29 |
|
|
2017
Q3 | $5M | Sell |
147,557
-6,823
| -4% | -$219K | 0.65% | 25 |
|
|
2017
Q2 | $4.92M | Sell |
154,380
-5,112
| -3% | -$161K | 0.64% | 22 |
|
|
2017
Q1 | $5.18M | Buy |
159,492
+1,635
| +1% | +$51.5K | 0.7% | 19 |
|
|
2016
Q4 | $4.86M | Sell |
157,857
-1,043
| -0.7% | -$31.8K | 0.72% | 19 |
|
|
2016
Q3 | $5.11M | Buy |
158,900
+20,180
| +15% | +$675K | 0.76% | 17 |
|
|
2016
Q2 | $4.63M | Sell |
138,720
-201
| -0.1% | -$6.42K | 0.76% | 15 |
|
|
2016
Q1 | $3.91M | Buy |
138,921
+15,454
| +13% | +$441K | 0.68% | 20 |
|
|
2015
Q4 | $3.78M | Sell |
123,467
-888
| -0.7% | -$27.9K | 0.68% | 19 |
|
|
2015
Q3 | $3.71M | Sell |
124,355
-4,866
| -4% | -$156K | 0.74% | 15 |
|
|
2015
Q2 | $4.11M | Sell |
129,221
-6,317
| -5% | -$206K | 0.76% | 16 |
|
|
2015
Q1 | $4.47M | Sell |
135,538
-1,095
| -0.8% | -$34.8K | 0.76% | 17 |
|
|
2014
Q4 | $4.04M | Sell |
136,633
-5,429
| -4% | -$156K | 0.62% | 19 |
|
|
2014
Q3 | $3.99M | Buy |
142,062
+11,858
| +9% | +$333K | 0.62% | 18 |
|
|
2014
Q2 | $3.67M | Sell |
130,204
-43,822
| -25% | -$1.25M | 0.58% | 21 |
|
|
2014
Q1 | $5.3M | Buy |
174,026
+32,449
| +23% | +$967K | 0.93% | 11 |
|
|
2013
Q4 | $4.11M | Buy |
141,577
+10,751
| +8% | +$313K | 0.97% | 12 |
|
|
2013
Q3 | $3.56M | Sell |
130,826
-1,825
| -1% | -$49.7K | 0.94% | 13 |
|
|
2013
Q2 | $3.52M | Buy |
+132,651
| New | +$3.67M | 0.97% | 11 |
|
Other funds holding PFE
Wedbush Securities's PFE Position: Q2 2026 in Review
Wedbush Securities reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $112K and leaving 202,441 shares worth $4.88M. The position accounts for 0.13% of the portfolio, ranked #123.
Wedbush Securities first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.2M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wedbush Securities held 202,441 shares of Pfizer worth $4.88M as of Q2 2026.
- Wedbush Securities sold 4,294 Pfizer shares in Q2 2026, an estimated $112K.
- Pfizer made up 0.13% of Wedbush Securities's portfolio in Q2 2026, its #123 holding.
- Wedbush Securities first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Wedbush Securities's Pfizer position peaked at $12.2M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.